Experienced in Calcium Pyrophosphate Arthritis

Hiroshi Nakajima

Chiba, JP 
Experienced in Calcium Pyrophosphate Arthritis
Chiba, JP 
OverviewLocationsClinical Research

Overview

Hiroshi Nakajima practices in Chiba, Japan. Mr. Nakajima is rated as an Experienced expert by MediFind in the treatment of Calcium Pyrophosphate Arthritis. His top areas of expertise are Synovitis, Kimura Disease, Rheumatoid Arthritis (RA), and Arthritis.

His clinical research consists of co-authoring 191 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Calcium Pyrophosphate Arthritis.

Gender
Male

Locations

Chiba, Japan
Other Locations
Sakado, 3500283, Japan
Chuo, Japan
Nishi, 8190395, Japan
Yushima, 1138510, Japan
Fukuoka, 8190395, Japan
Saitama, Japan
Atsugi, 2430014, Japan
St. Marianna University School of Medicine
Kawasaki, Japan
Chiyoda, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Enrollment Status: Unknown
Publish Date: January 27, 2021
Intervention Type: Drug
Study Drugs: Rituximab, Glucocorticoids
Study Phase: Phase 4

191 Total Publications

Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study.
Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study.
Journal: Immunological medicine
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nakajima's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile